Last 47 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Encompass Health Corporation's quarterly P/E stands at 25.6x, up 12.4% year-over-year — indicating the stock has re-rated higher or earnings have softened. EV/EBITDA has expanded 10.4% YoY to 12.0x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 19.44 | 25.61 | 22.06 | 17.11 | 19.57 | 22.79 | 19.15 | 18.77 | 19.40 | 19.99 | 18.81 | 15.55 | 16.99 |
| — | +12.4% | +15.2% | -8.8% | +0.9% | +14.0% | +1.8% | +20.7% | +14.1% | -20.5% | -17.3% | -4.3% | +19.2% | |
| P/S Ratio | 1.82 | 2.20 | 2.15 | 1.78 | 1.68 | 1.83 | 1.68 | 1.60 | 1.36 | 1.41 | 1.44 | 1.18 | 1.33 |
| — | +20.4% | +27.8% | +10.8% | +23.8% | +29.4% | +16.6% | +36.3% | +2.5% | +35.2% | +37.1% | -12.0% | +34.4% | |
| P/B Ratio | 3.37 | 4.08 | 4.06 | 3.52 | 3.32 | 3.62 | 3.46 | 3.51 | 2.95 | 3.11 | 3.33 | 2.78 | 3.24 |
| — | +12.7% | +17.3% | +0.2% | +12.5% | +16.4% | +3.9% | +26.3% | -9.0% | +19.6% | +89.4% | +22.3% | +49.4% | |
| P/FCF | — | 38.81 | 27.65 | 20.60 | 29.49 | 20.50 | 36.16 | 21.23 | — | 24.85 | 19.12 | 10.39 | — |
| — | +89.3% | -23.5% | -3.0% | — | -17.5% | +89.1% | +104.2% | — | — | +113.7% | -23.9% | — | |
| EV / EBITDA | 10.09 | 11.97 | 11.12 | 9.35 | 9.73 | 10.84 | 9.98 | 10.07 | 4.66 | 4.82 | 4.80 | 4.15 | 9.26 |
| — | +10.4% | +11.5% | -7.1% | +108.7% | +125.0% | +108.0% | +142.6% | -49.7% | -45.4% | -48.0% | -60.2% | +5.6% | |
| EV / EBIT | 14.45 | 15.56 | 14.11 | 11.97 | 12.88 | 14.25 | 13.07 | 13.09 | 12.64 | 13.37 | 13.09 | 11.25 | 11.94 |
| — | +9.2% | +8.0% | -8.6% | +1.9% | +6.6% | -0.2% | +16.4% | +5.8% | +4.6% | -3.3% | -23.3% | +3.7% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Encompass Health Corporation's operating margin was 16.5% in Q3 2025, down 1.3 pp QoQ and up 1.0 pp YoY. This marks the 3rd consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. Gross margin expanded 13.5% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 47.5% | 46.9% | 43.0% | 43.3% | 41.7% | 41.3% | 41.7% | 41.5% | 41.1% | 41.0% | 42.0% | 41.2% | 95.3% |
| — | +13.5% | +3.0% | +4.5% | +1.6% | +0.9% | -0.7% | +0.8% | -56.9% | -57.0% | -56.0% | -56.8% | -0.7% | |
| Operating Margin | 12.8% | 16.5% | 17.8% | 18.3% | 16.5% | 15.5% | 16.6% | 15.8% | 35.7% | 35.7% | 36.2% | 36.2% | 15.8% |
| — | +6.5% | +7.3% | +16.4% | -53.7% | -56.6% | -54.2% | -56.5% | +125.8% | +161.8% | +157.0% | +151.5% | +15.6% | |
| Net Margin | 9.5% | 8.6% | 9.7% | 10.4% | 8.6% | 8.0% | 8.8% | 8.5% | 7.0% | 7.1% | 7.7% | 7.6% | 7.9% |
| — | +6.9% | +11.2% | +21.8% | +22.5% | +13.3% | +13.9% | +13.1% | -10.6% | +69.6% | +68.0% | -8.5% | +13.2% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 18.5% | 4.0% | 4.7% | 5.2% | 4.3% | 4.1% | 4.6% | 4.8% | 3.9% | 4.0% | 4.5% | 4.6% | 5.0% |
| — | -2.1% | +2.0% | +9.4% | +11.1% | +2.5% | +1.7% | +4.4% | -21.2% | +89.9% | +135.1% | +28.2% | +26.9% | |
| ROA | 8.3% | 1.9% | 2.1% | 2.3% | 1.9% | 1.7% | 1.8% | 1.8% | 1.5% | 1.4% | 1.6% | 1.5% | 1.6% |
| — | +10.0% | +17.1% | +26.1% | +28.2% | +16.8% | +14.8% | +18.4% | -9.8% | +99.5% | +126.8% | +21.6% | +19.3% | |
| ROIC | 12.7% | 3.2% | 3.5% | 3.6% | 3.2% | 3.0% | 3.1% | 3.0% | 6.6% | 6.6% | 6.9% | 6.7% | 2.8% |
| — | +8.2% | +12.2% | +20.0% | -51.2% | -55.1% | -54.9% | -55.0% | +132.1% | +209.0% | +249.4% | +236.0% | +17.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Encompass Health Corporation's Debt/EBITDA ratio is 8.2x, up from 7.9x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 9.7% YoY to 1.14x, strengthening the short-term liquidity position. Debt/Equity has declined for 10 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.08 | 0.84 | 0.87 | 0.92 | 0.95 | 1.03 | 1.16 | 1.21 | 1.28 | 1.34 | 1.43 | 1.36 | 1.61 |
| — | -18.7% | -25.3% | -24.3% | -25.4% | -23.1% | -18.5% | -10.5% | -20.6% | -20.9% | +2.9% | +5.5% | +10.8% | |
| Debt / EBITDA | 0.25 | 8.16 | 7.92 | 7.81 | 8.75 | 9.74 | 10.21 | 10.51 | 5.70 | 5.88 | 5.86 | 5.50 | 12.31 |
| — | -16.2% | -22.4% | -25.7% | +53.5% | +65.7% | +74.3% | +91.0% | -53.7% | -58.1% | -65.2% | -63.9% | -13.0% | |
| Current Ratio | 1.08 | 1.14 | 1.06 | 1.06 | 1.05 | 1.04 | 1.35 | 1.37 | 1.28 | 1.27 | 1.26 | 1.29 | 1.25 |
| — | +9.7% | -21.4% | -22.1% | -17.8% | -18.3% | +7.4% | +6.2% | +3.0% | +4.9% | +1.8% | +2.2% | +1.2% | |
| Quick Ratio | 1.08 | 1.14 | 1.06 | 1.06 | 1.05 | 1.04 | 1.35 | 1.37 | 1.28 | 1.27 | 1.26 | 1.29 | 1.25 |
| — | +9.7% | -21.4% | -22.1% | -17.8% | -18.3% | +7.4% | +6.2% | +3.0% | +4.9% | +1.8% | +2.2% | +1.2% | |
| Interest Coverage | 6.17 | 7.91 | 8.52 | 8.40 | 7.04 | 5.99 | 6.29 | 5.89 | 12.74 | 11.99 | 11.82 | 11.55 | 4.79 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonEncompass Health Corporation's current P/E is 19.4x. The average P/E over the last 4 quarters is 21.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Encompass Health Corporation's current operating margin is 12.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Encompass Health Corporation's business trajectory between earnings reports.